Fig. 3From: Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trialTreatment groups. ATO, arsenic trioxide; ATRA, all-trans retinoic acid; APL, acute promyelocytic leukemia; HCR, hematologic complete remission; MCR, molecular complete remission; RIF, realgar-indigo naturalis formulaBack to article page